An AI framework developed by Nashville, Tenn.-based Vanderbilt University identified statin intolerance, contraindications and patient deferrals documented in clinical notes for 10% of adult patients.

Seventy-six percent of oncologists reported seeing an increasing number of patients presenting with advanced-stage cancer. Of those, 75% attributed the increase to screening barriers, according to a ...